Investors

Marinus is committed to maximizing shareholder value by developing and commercializing ganaxolone for treatment of drug-resistant seizures in both the hospital and home settings.

NASDAQ: MRNS
$ 1.36 0.00 (0.00%)
Day High: 1.42
Day Low:  1.33
Volume:    147,353
4:00 PM ET
Jun 23, 2017

Delayed ~20 min., by eSignal.